2019
DOI: 10.1021/acs.orglett.9b01721
|View full text |Cite
|
Sign up to set email alerts
|

Rhodium-Catalyzed Enantioselective Cyclization of 3-Allenyl-indoles: Access to Functionalized Tetrahydrocarbazoles

Abstract: Figure 1. Selected tetrahydrocarbazole (THC) natural products and structurally related alkaloids. Scheme 1. Transition-Metal Catalyzed Strategies for the Synthesis of Enantioenriched 1-Vinyltetra-hydrocarbazoles Letter pubs.acs.org/OrgLett

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
18
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 31 publications
(18 citation statements)
references
References 45 publications
(13 reference statements)
0
18
0
Order By: Relevance
“…The oxo-indole functionalization was observed after treatment with TFA (Scheme 24b, right). [60] Interestingly, Breit has recently reported the enantioselective reaction of related allenes 105 in the presence of rhodium catalysts to give the tetrahydrocarbazole core 107 via the formation of spirocycle intermediates 106 [61] that can also be trapped in situ with a reductant to give functionalized vinylic spiroindoles 108 (Scheme 24c). [62] Cationic gold species have promoted the dihydrocarbazole synthesis from compounds 109, in which indole and allene are separated by one carbon, unraveling a complex reaction mechanism where C3 vs. C2 indole nucleophilicity competes yielding a mixture of carbocyclization products 110 and rearrangement products 111 trough spirocyclic intermediates (112, Scheme 25a).…”
Section: Indole As C2-nucleophilementioning
confidence: 99%
See 1 more Smart Citation
“…The oxo-indole functionalization was observed after treatment with TFA (Scheme 24b, right). [60] Interestingly, Breit has recently reported the enantioselective reaction of related allenes 105 in the presence of rhodium catalysts to give the tetrahydrocarbazole core 107 via the formation of spirocycle intermediates 106 [61] that can also be trapped in situ with a reductant to give functionalized vinylic spiroindoles 108 (Scheme 24c). [62] Cationic gold species have promoted the dihydrocarbazole synthesis from compounds 109, in which indole and allene are separated by one carbon, unraveling a complex reaction mechanism where C3 vs. C2 indole nucleophilicity competes yielding a mixture of carbocyclization products 110 and rearrangement products 111 trough spirocyclic intermediates (112, Scheme 25a).…”
Section: Indole As C2-nucleophilementioning
confidence: 99%
“…The oxo‐indole functionalization was observed after treatment with TFA (Scheme 24b, right). [ 60 ] Interestingly, Breit has recently reported the enantioselective reaction of related allenes 105 in the presence of rhodium catalysts to give the tetrahydrocarbazole core 107 via the formation of spirocycle intermediates 106 [ 61 ] that can also be trapped in situ with a reductant to give functionalized vinylic spiroindoles 108 (Scheme 24c). [ 62 ]…”
Section: Intramolecular Reactionsmentioning
confidence: 99%
“…1 Compared to their linear counterparts, cyclic peptides often possess enhanced target affinity and specificity, improved half-lives due to resistance to exo-and endopeptidases, and enhanced cell permeability. 1,2 By majority, these improved properties stem from the reduced conformational freedom of cyclic peptides and lack of carboxyl and amino termini. 1,2 These favourable attributes and their capacity to act on intracellular targets, unlike monoclonal antibodies, have resulted in cyclic peptides attracting significant attention as new therapeutic agents.…”
mentioning
confidence: 99%
“…1,2 By majority, these improved properties stem from the reduced conformational freedom of cyclic peptides and lack of carboxyl and amino termini. 1,2 These favourable attributes and their capacity to act on intracellular targets, unlike monoclonal antibodies, have resulted in cyclic peptides attracting significant attention as new therapeutic agents. Importantly, several cyclic peptides such as vancomyin, cyclosporine A, daptomycin, integrilin, octreotide, plecanatide and linaclotide have been approved for clinical use.…”
mentioning
confidence: 99%
See 1 more Smart Citation